AMLX NASDAQ
Amylyx Pharmaceuticals, Inc.
1W: +5.7%
1M: +9.9%
3M: +15.8%
YTD: +71.2%
1Y: +139.9%
3Y: -13.3%
$19.55
+0.06 (+0.31%)
Weekly Expected Move ±7.6%
$16
$17
$18
$20
$21
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.2B
52W Range7.48-19.99
Volume2,871,200
Avg Volume1,463,634
Beta-0.20
Dividend$1.02
Analyst Ratings
Company Info
CEOJoshua Cohen
Employees136
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-07
Websiteamylyx.com
43 Thorndike Street
Cambridge, MA 02141
US
Cambridge, MA 02141
US
617 682 0917
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Latest News
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data?
Amylyx Stock: Why the Full Pipeline Story Matters
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 2026 Results and Pipeline Progress
Amylyx (AMLX) Q1 2026 Earnings Transcript
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Mazzariello Gina | S-Sale | 15,000 | $17.61 | 2026-07-10 |
| Mazzariello Gina | S-Sale | 15,000 | $18.32 | 2026-07-09 |
| Zeiher Bernhardt G | A-Award | 24,372 | $14.31 | 2026-06-04 |
| Firestone Karen | A-Award | 24,372 | $14.31 | 2026-06-04 |
| Quimi Daphne | A-Award | 24,372 | $14.31 | 2026-06-04 |